Skip to main content Accessibility help

The combined treatment of praziquantel with osteopontin immunoneutralization reduces liver damage in Schistosoma japonicum-infected mice

  • BO-LIN CHEN (a1), GUI-YING ZHANG (a1), SHI-PING WANG (a2), QIAN LI (a1), MEI-HUA XU (a1), YUE-MING SHEN (a3), LU YAN (a1), HUAN GU (a1), JIA LI (a1), Y. L. HUANG (a4) and YI-BING MU (a1)...


The aim of this study was to evaluate the therapeutic effects of osteopontin neutralization treatment on schistosome-induced liver injury in BALB/C mice. We randomly divided 100 BALB/C mice into groups A, B, C, D and group E. Mice in all groups except group A were abdominally infected with schistosomal cercariae to induce a schistosomal hepatopathological model. Mice in group C, D and group E were respectively administered with praziquantel, praziquantel plus colchicine and praziquantel plus neutralizing osteopontin antibody. We extracted mouse liver tissues at 3 and 9 weeks after the ‘stool-eggs-positive’ day, observed liver histopathological changes by haematoxylin-eosin and Masson trichrome staining and detected the expression of osteopontin, alpha-smooth muscle actin (α-SMA) and transforming growth factor-beta (TGF-β1) by immunohistochemistry, RT-PCR and Western blot. We found that praziquantel plus neutralizing osteopontin antibody treatment significantly decreased the granuloma dimension, the percentage of collagen and the expression of osteopontin, α-SMA and TGF-β1 compared to praziquantel plus colchicine treatment in both the acute and chronic stage of schistosomal liver damage (P<0·05). So we believe that the combined regimen of osteopontin immunoneutralization and anti-helminthic treatment can reduce the granulomatous response and liver fibrosis during the schistosomal hepatopathologic course.


Corresponding author

*Corresponding author: Department of Gastroenterology, Xiangya Hospital, Central South University, Changsha, 410008, Hunan Province,China. Tel: +86 1387 3186462. Fax: +86 0731 84327321. E-mail:


Hide All
Anthony, B., Allen, J. T., Li, Y. S. and McManus, D. P. (2010). Hepatic stellate cells and parasite-induced liver fibrosis. Parasites & Vectors 3, 60. doi: 10.1186/1756-3305-3-60.
Bartley, P. B., Ramm, G. A., Jones, M. K., Ruddell, R. G., Li, Y. and McManus, D. P. (2006). A contributory role for activated hepatic stellate cells in the dynamics of Schistosoma japonicum egg-induced fibrosis. International Journal for Parasitology 36, 9931001. doi: 10.1016/j.ijpara.2006.04.015.
Bergquist, R. and Tanner, M. (2010). Controlling schistosomiasis in Southeast Asia: a tale of two countries. Advances in Parasitology 72, 109144. doi: 10.1016/S0065-308X(10)72005-4.
Burke, M. L., Jones, M. K., Gobert, G. N., Li, Y. S., Ellis, M. K. and McManus, D. P. (2009). Immunopathogenesis of human schistosomiasis. Parasite Immunology 31, 163176. doi: 10.1111/j.1365-3024.2009.01098.x.
Chabas, D. (2005). Osteopontin, a multi-faceted molecule. Medecine Sciences (Paris) 21, 832888. doi: 10.1051/medsci/20052110832.
Chapadeiro, E. and Pitanga, L. C. (1996). On the reversal of schistosomiasis hepatic fibrosis after specific therapy. Histopathologic study. Revista da Sociedade Brasileira de Medicina Tropical 30, 5356.
Chen, B. L., Zhang, G. Y., Yuan, W. J., Wang, S. P., Shen, Y. M., Yan, L., Gu, H. and Li, J. (2011). Osteopontin expression is associated with hepatopathologic changes in Schistosoma japonicum–infected mice. World Journal of Gastroenterology 17, 50755082.
Coutinho, H. M., Acosta, L. P., Wu, H. W., McGarvey, S. T., Su, L., Langdon, G. C., Jiz, M. A., Jarilla, B., Olveda, R. M., Friedman, J. F. and Kurtis, J. D. (2007). Th2 cytokines are associated with persistent hepatic fibrosis in human Schistosoma japonicum infection. The Journal of Infectious Diseases 195, 288295. doi: 10.1086/510313.
Doenhoff, M. J., Kusel, J. R., Coles, G. C. and Cioli, D. (2002). Resistance of Schistosoma mansoni to praziquantel: is there a problem? Transactions of the Royal Society of Tropical Medicine and Hygiene 96, 465469.
Fornari, A., Rhoden, E. L., Zettler, C. G., Ribeiro, E. P. and Rhoden, C. R. (2011). Effects of the chronic use of finasteride and doxazosin mesylate on the histomorphometric characteristics of the prostate: experimental study in rats. International Urology and Nephrology 43, 3945. doi: 10.1007/s11255-010-9770-3.
Gabele, E., Brenner, D. A. and Rippe, R. A. (2003). Liver fibrosis: signals leading to the amplification of the fibrogenic hepatic stellate cell. Frontiers in Bioscience 8, 6977. doi: 10.2741/887.
Garjito, T. A., Sudomo, M., Abdullah, , Dahlan, M. and Nurwidayati, A. (2008). Schistosomiasis in Indonesia: past and present. Parasitology International 57, 277280. doi: 10.1016/j.parint.2008.04.008.
Giachelli, C. M. and Steitz, S. (2000). Osteopontin: A versatile regulator of inflammation and biomineralization. Matrix Biology 19, 615622. doi: 10.1016/S0945-053X(00)00108-6.
Gryseels, B., Polman, K., Clerinx, J. and Kestens, L. (2006). Human schistosomiasis. The Lancet 368, 11061118. doi: 10.1016/S0140-6736(06)69440-3.
Kiefer, F. W., Zeyda, M., Gollinger, K., Pfau, B., Neuhofer, A., Weichhart, T., Säemann, M. D., Geyeregger, R., Schlederer, M., Kenner, L. and Stulnig, T. M. (2010). Neutralization of osteopontin inhibits obesity-induced inflammation and insulin resistance. Diabetes 59, 935946. doi: 10.2337/db09-0404.
Lenga, Y., Koh, A., Perera, A. S., McCulloch, C. A., Sodek, J. and Zohar, R. (2008). Osteopontin expression is required for myofibroblast differentiation. Circulation Research 102, 319327. doi: 10.1161/circresaha.107.160408.
Lorena, D., Darby, I. A., Gadeau, A. P., Leen, L. L., Rittling, S., Porto, L. C., Rosenbaum, J. and Desmoulière, A. (2006). Osteopontin expression in normal and fibrotic liver. Altered liver healing in osteopontin-deficient mice. Journal of Hepatology 44, 383390. doi:10.1016/j.jhep.2005.07.024.
McManus, D. P., Li, Y., Gray, D. J. and Ross, A. G. (2009). Conquering ‘snail fever': schistosomiasis and its control in China. Expert Review of Anti-infective Therapy 7, 473485. doi: 10.1586/eri.09.17.
Moreira, R. K. (2007). Hepatic stellate cells and liver fibrosis. Archives of Pathology & Laboratory Medicine 131, 17281734.
Morimoto, J., Kon, S., Matsui, Y. and Uede, T. (2010). Osteopontin; as a target molecule for the treatment of inflammatory diseases. Current Drug Targets 11, 494505.
O'Regan, A. and Berman, J. S. (2000). Osteopontin: A key cytokine in cell mediated and granulomatous inflammation. International Journal of Experimental Pathology 81, 373390. doi: 10.1046/j.1365-2613.2000.00163.x.
Paiva, L. A., Maya-Monteiro, C. M., Bandeira-Melo, C., Silva, P. M., El-Cheikh, M. C., Teodoro, A. J., Borojevic, R., Perez, S. A. and Bozza, P. T. (2010). Interplay of cysteinyl leukotrienes and TGF-β in the activation of hepatic stellate cells from Schistosoma mansoni granulomas. Biochimica et Biophysica Acta 1801, 13411348. doi: 10.1016/j.bbalip.2010.08.014.
Ramaiah, S. K. and Rittling, S. (2008). Pathophysiological role of osteopontin in hepatic inflammation, toxicity, and cancer. Toxicological Sciences 103, 413. doi: 10.1093/toxsci/kfm246.
Reeves, H. L. and Friedman, S. L. (2002). Activation of hepatic stellate cells – a key issue in liver fibrosis. Frontiers in Bioscience 7, d808d826. doi: 10.2741/reeves.
Shimada, M., Kirinoki, M., Shimizu, K., Kato-Hayashi, N., Chigusa, Y., Kitikoon, V., Pongsasakulchoti, P. and Matsuda, H. (2010). Characteristics of granuloma formation and liver fibrosis in murine schistosomiasis mekongi: a morphological comparison between Schistosoma mekongi and S. japonicum infection. Parasitology 137, 17811789. doi: 10.1017/S0031182010000806.
Singh, M., Foster, C. R., Dalal, S. and Singh, K. (2010). Osteopontin: role in extracellular matrix deposition and myocardial remodeling post-MI. Journal of Molecular and Cellular Cardiology 48, 538543. doi: 10.1016/j.yjmcc.2009.06.015.
Ueno, T., Miyazaki, E., Ando, M., Nureki, S. and Kumamoto, T. (2010). Osteopontin levels are elevated in patients with eosinophilic pneumonia. Respirology 15, 11111121. doi: 10.1111/j.1440-1843.2010.01825.x.
von Lichtenberg, F. V. (1962). Host response to eggs of S. mansoni. I. Granuloma formation in the unsensitized laboratory mouse. The American Journal of Pathology 41, 711731.
Wada, W., Kuwano, H., Hasegawa, Y. and Kojima, I. (2004). The dependence of transforming growth factor-beta-induced collagen production on autocrine factor activin A in hepatic stellate cells. Endocrinology 145, 27532759. doi: 10.1210/en.2003-1663.
Xu, X., Wen, X., Chi, Y., He, L., Zhou, S., Wang, X., Zhao, J., Liu, F. and Su, C. (2010). Activation-induced T helper cell death contributes to Th1/Th2 polarization following murine Schistosoma japonicum infection. Journal of Biomedicine and Biotechnology 2010, 202397. doi: 10.1155/2010/202397.


Related content

Powered by UNSILO

The combined treatment of praziquantel with osteopontin immunoneutralization reduces liver damage in Schistosoma japonicum-infected mice

  • BO-LIN CHEN (a1), GUI-YING ZHANG (a1), SHI-PING WANG (a2), QIAN LI (a1), MEI-HUA XU (a1), YUE-MING SHEN (a3), LU YAN (a1), HUAN GU (a1), JIA LI (a1), Y. L. HUANG (a4) and YI-BING MU (a1)...


Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed.